[optimal] Re: (no subject)

  • From: "Steffens, Timothy" <tjsteffe@xxxxxxxxxxxxx>
  • To: "optimal@xxxxxxxxxxxxx" <optimal@xxxxxxxxxxxxx>
  • Date: Fri, 24 Apr 2015 18:13:48 +0000

Only for one clinical trial.

Tim Steffens

From: optimal-bounce@xxxxxxxxxxxxx [mailto:optimal-bounce@xxxxxxxxxxxxx] On
Behalf Of Paula Morris
Sent: Friday, April 24, 2015 12:35 PM
To: optimal@xxxxxxxxxxxxx
Subject: [optimal] (no subject)

Hello colleagues,

I have received an inquiry from the UK about how often Spectralis users in the
US enter the c-curve information when imaging clinical patients, not just in
clinical trials.

Thanks so much for sharing,

P
**********************************************************
Electronic Mail is not secure, may not be read every day, and should not be
used for urgent or sensitive issues

Other related posts: